๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› China
Clinical trial register · China

Studies with a Chinese investigative site

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the register
Recruitment status
Phase
Lead sponsor
Sun Yat-sen University490 Fudan University472 Second Affiliated Hospital, Zhejiang University, School of Medicine404 Peking Union Medical College Hospital282 Ruijin Hospital281
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to
19052 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
A Phase I Clinical Study of AK150 in Advanced Malignant Solid Tumor
NCT07566247Advanced Malignant Solid Tumors
Akeso
Phase 1
96
Fuzhou, Dongguan, Wuhan
2026-04-30
Not yet open
A Study on the Therapeutic Value of Additional Left Atrial Posterior Wall Isolation Guided by Voltage Mapping in Persistent Atrial Fibrillation.
NCT07590661Persistent Atrial Fibrillation
Hangzhou Dinova EP Technology Co., Ltd
Not applicable
350
Kunming
2026-04-30
Not yet open
Safety and Preliminary Efficacy of hUCMSC-EVs in Interstitial Lung Disease
NCT07570836Interstitial Lung Disease (ILD)
Shanghai Zhongshan Hospital
Phase 1
24
Shanghai
2026-04-30
Recruiting
The Effect of Sequential Therapy on Alzheimer's Disease
NCT07768579Mild Cognitive Impairment Due to Alzheimer Disease, Alzheimer Disease
Dongzhimen Hospital, Beijing
Observational
600
Beijing
2026-04-30
Active, closed
National Cohort Study on Infant Gut Microbiota and Nutrition
NCT07705685Fecal Gut Microbiota
DiproBio (Shanghai) Co., Ltd.
Observational
106,667
Shanghai
2026-04-30
Recruiting
Phase II Study of Trastuzumab Rezetecan Combined With Adebrelimab and Lenvatinib as First-Line Therapy for Advanced HER2-Positive/HER2-Low Biliary Tract Cancer
NCT07670273Biliary Tract Neoplasms Immunotherapy
Peking Union Medical College Hospital
Phase 2
70
Beijing
2026-04-29
Recruiting
Prospective Clinical Trial of 177Lu-P17-088 in the Treatment of Metastatic Castration-Resistant Prostate Cancer
NCT07562438Prostate Cancer
First Affiliated Hospital of Fujian Medical University
Phase 2
20
Fuzhou
2026-04-29
Recruiting
A Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome-Constipation (IBS-C)
NCT07545772Irritable Bowel Syndrome, Constipation
Eli Lilly and Company
Phase 2
342
Binzhou, Chengdu, Guangzhou, Hangzhou, Hengyang, Huizhou, Huzhou, Meihekou
2026-04-29
Recruiting
A Phase II Study of AMT-676 Combination Therapies in Advanced Colorectal Cancer
NCT07474727Colorectal Cancer
Multitude Therapeutics Inc.
Phase 2
180
Fuzhou, Nanning, Guangzhou, Harbin, Luoyang, Wuhan, Changsha, Shengyang
2026-04-29
Recruiting
A Multi-centre Chart Review Study of Stage I-III Non-Small Cell Lung Cancer in China
NCT07316062Non-Small-Cell Lung
AstraZeneca
Observational
3,000
Beijing
2026-04-29
Recruiting
A Phase II Clinical Trial of SHR-1826 for Non-Small Cell Lung Cancer
NCT07489716Non-Small Cell Lung Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 2
90
Jinan
2026-04-29
Active, closed
Topical Chinese Medicine and Exosome Mechanisms for Atopic Dermatitis
NCT07693400Atopic Dermatitis (AD)
Taiwan Municipal An-Nan Hospital-China Medical University
Phase 2
44
2026-04-29
Not yet open
Effects of High-frequency Left Dorsolateral Prefrontal rTMS on Heart-brain Coupling in Women With Recurrent Pregnancy Loss and Elevated BMI
NCT07561931Recurrent Pregnancy Loss, Overweight , Obesity, Heart-Brain Coupling
Shenyang Medical College
Not applicable
60
Shenyang
2026-04-28
Not yet open
A Multimodal Convergent Cohort of Parkinson's Disease at FJMUUH (FJMUUH-PD): Natural History Study
NCT07588763Parkinson Disease (PD)
Fujian Medical University Union Hospital
Observational
3,000
Fujian
2026-04-28
Recruiting
Implantable Wireless Brain-Machine Interface System for Spinal Cord Injury: Efficacy and Safety Study
NCT07603752Spinal Cord Injury
Shanghai StairMed Technology Co., Ltd.
Not applicable
34
Shanghai
2026-04-28
Recruiting
Au-TMP and Radiotherapy for Advanced Melanoma With Anti-PD-1 Therapy
NCT07562841Advanced Melanoma
West China Hospital
Phase 1
6
Chengdu
2026-04-28
Recruiting
Safety and Preliminary Efficacy of [177Lu]Lu-RTX-2358 Combined With Immune Checkpoint Inhibitors in Patients With FAP-positive Metastatic Non-Small Cell Lung Cancer
NCT07689643Metastatic Non-small Cell Lung Cancer
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase EARLY_PHASE1
36
Wuhan
2026-04-28
Not yet open
Iparomlimab and Tuvonralimab Combined With SFRT and Definitive Chemoradiotherapy in Locoregionally Advanced Bulky HNSCC
NCT07041788Cancer
Second Affiliated Hospital of Nanchang University
Phase 2
25
Nanchang
2026-04-28
Recruiting
A Study to Compare Setidegrasib (ASP3082) With Docetaxel, in People With Non-small Cell Lung Cancer With a KRAS G12D Mutation
NCT07566052Non-small Cell Lung Cancer (NSCLC)
Astellas Pharma Global Development, Inc.
Phase 3
356
Guangzhou, Hangzhou
2026-04-28
Recruiting
Safety and Tolerability of AI-Designed Pan-Cancer Neoantigen mRNA Vaccine (PAN-NeoVax) in Advanced Solid Tumors
NCT07560943Cancer
West China Hospital
Phase 1
9
Chengdu
2026-04-28
Not yet open
Safety and Tolerability of NCP-IL-22BP mRNA in Advanced Solid Tumors
NCT07562815Cancer
West China Hospital
Phase 1
9
Chengdu
2026-04-28
Recruiting
A Trial of Trastuzumab Rezetecan in Unresectable Locally Recurrent/Metastatic Breast Cancer
NCT07497386Unresectable Locally Recurrent Breast Cancer, Unresectable Locally Metastatic Breast Cancer
Jiangsu HengRui Medicine Co., Ltd.
Phase 2
150
Beijing
2026-04-28
Recruiting
A Study of Becotatug Vedotin (MRG003) Combined With Epirubicin as Neoadjuvant Therapy for EGFR-Positive, Unresectable Recurrent Sinonasal Adenoid Cystic Carcinoma
NCT07522879Adenoid Cystic Carcinoma, Sinonasal Carcinoma
Eye & ENT Hospital of Fudan University
Phase 2
40
Shanghai
2026-04-28
Recruiting
Clinical Study of a Facial Cream for Rosacea
NCT07637032Facial Rosacea
ChinaNorm
Not applicable
76
Shanghai
2026-04-28
Recruiting
Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP
NCT07354074Chronic Myelogenous Leukemia, Leukemia, Myelogenous, Chronic, Philadelphia Chromosome Positive
Novartis Pharmaceuticals
Phase 2
50
Zhengzhou, Tianjin
2026-04-28
Recruiting
A Study to Learn About Salanersen's (BIIB115) Effects on Movement and Its Safety When Given Before Symptoms Appear in Babies With Genetically Diagnosed Spinal Muscular Atrophy (SMA)
NCT07221669Muscular Atrophy, Spinal
Biogen
Phase 3
30
Zhengzhou, Guangzhou, Shanghai
2026-04-28
Active, closed
Anisodine Hydrobromide for Patients With Acute Ischemic Stroke Undergoing Endovascular Therapy (HEAL)
NCT07513233Acute Ischemic Stroke
Capital Medical University
Phase 1
92
Zhangzhou, Jiuquan, Yulin, Shangqiu, Xuzhou, Beijing, Zibo, Huzhou
2026-04-28
Recruiting
A Study to Learn How Well a Combination of Darolutamide and Androgen Deprivation Therapy (ADT) Works as a Treatment Before Surgery for Men Who Have High-risk Localized Prostate Cancer.
NCT07450599High-risk Localized Prostate Cancer
Bayer
Phase 2
250
Hefei, Beijing, Fuzhou, Lanzhou, Guangzhou, Shijiazhuang, Harbin, Zhengzhou
2026-04-27
By invitation
A Coronary Computed Tomography Angiography-guided Intervention for High Risk Cardiovascular Disease Population in Rural China
NCT07416344Coronary Artery Disease
Harbin Medical University
Not applicable
14,980
Daqing, Harbin, Hegang, Jiamusi, Mudanjiang, Qiqihar, Shuangyashan, Suihua
2026-04-27
Recruiting
18F-T2 PET/CT Imaging for CAIX Positive Solid Tumors
NCT07557225Clear Cell Renal Cell Cancer (ccRCC), Urothelial Carcinoma (UC), Colorectal Cancer, Cervical Cancer
Peking University First Hospital
Not applicable
200
Beijing
2026-04-27
Recruiting
Phase II Clinical Study of BC006 in Patients With Idiopathic Pulmonary Fibrosis
NCT07447102Idiopathic Pulmonary Fibrosis (IPF)
Dragonboat Biopharmaceutical Company Limited
Phase 2
96
Shanghai
2026-04-27
Recruiting
Research on the Efficacy and Safety of Targeted Suprachiasmatic Nucleus Electrical Stimulation for Improving Metabolic Disorders in Patients With Stable Bipolar Disorder Comorbid With Obesity
NCT07589647Bipolar Disorder (BD)
First Affiliated Hospital of Zhejiang University
Not applicable
70
Hangzhou
2026-04-27
Recruiting
Transcutaneous Auricular Vagus Nerve Stimulation for Preventing Acute Kidney Injury in Patients Undergoing Cardiac Surgery With Cardiopulmonary Bypass
NCT07549243Acute Kidney Injury, Cardiac Surgery, Cardiopulmonary Bypass
Sir Run Run Shaw Hospital
Not applicable
152
Hangzhou
2026-04-27
Active, closed
Development and Validation of an AI Foundation Model for Frozen-Section Pathology
NCT07708207Cancer, Intraoperative Pathology, Artificial Intelligence (AI)
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Observational
33,000
Guangzhou
2026-04-27
Recruiting
Mesenchymal Stem Cells in the Treatment of Burn Wounds
NCT07580755Burn Injury, Burn Patients
The First Affiliated Hospital of Xinxiang Medical College
Not applicable
90
Xinxiang
2026-04-27
Not yet open
Evaluate the Efficacy and Safety of GZR18 Injection in Obese Subjects With Obstructive Sleep Apnea Not Treated With Positive Airway Pressure (PAP) Therapy
NCT07493057Obstructive Sleep Apnea (OSA)
Gan & Lee Pharmaceuticals.
Phase 3
140
Beijing
2026-04-27
Recruiting
A Clinical Study to Evaluate the Effects of NXT007 Compared to Emicizumab Prophylaxis in People With Hemophilia A
NCT07416604Hemophilia A
Hoffmann-La Roche
Phase 3
360
Guangzhou, Chengdu, Tianjin
2026-04-27
Recruiting
Open-Label Study of Dimethyl Fumarate in Adults With Type 1 Diabetes
NCT07548996Type 1 Diabetes Mellitus
Nanjing Medical University
Phase 2/3
96
Nanjing
2026-04-27
Recruiting
Evaluate the Efficacy and Safety of ICP-488 in Subjects With Cutaneous Lupus Erythematosus (CLE) Double-blind Study
NCT07440537Cutaneous Lupus Erythematosus (CLE)
Beijing InnoCare Pharma Tech Co., Ltd.
Phase 2
105
Hefei, Beijing, Chongqing, Fuzhou, Dongguan, Guangzhou, Shijiazhuang, Zhengzhou
2026-04-27
Not yet open
Echo-Guided vs Fluoroscopy-Guided Transcatheter Aortic Valve Replacement in Patients With Aortic Stenosis๏ผˆECHO-TAVR๏ผ‰
NCT07317804Aortic Stenosis, TAVI, TAVI(Transcatheter Aortic Valve Implantation)
China National Center for Cardiovascular Diseases
Phase 4
212
Beijing
2026-04-26
Recruiting
Oxytocin's Effects on Real Time-fMRI Neurofeedback Training of Anterior Insula Activity
NCT07559656Healthy
University of Electronic Science and Technology of China
Not applicable
80
Chengdu
2026-04-26
Recruiting
Phase 1 Clinical Study of MWN105 Injection in Participants With Overweight or Obesity
NCT07803809Overweight , Obesity, Type 2 Diabetes Mellitus (T2DM), MASH - Metabolic Dysfunction-Associated Steatohepatitis
Shanghai Minwei Biotechnology Co., Ltd
Phase 1
36
Kunming
2026-04-26
Not yet open
The Efficacy of an AI-Based Rehabilitation Treatment in Patients With Anxiety Disorders
NCT07545070Anxiety Disorders
Shanghai Mental Health Center
Not applicable
158
Shanghai
2026-04-25
Not yet open
Extended Sentinel Lymph Node Biopsy With Methylene Blue Single Tracer Post-Neoadjuvant Therapy for Node-Positive Breast Cancer
NCT07532096Breast Cancer
Xijing Hospital
Not applicable
240
Xi'an
2026-04-25
Recruiting
Simplified Dual Regimen Guided by Fecal Clarithromycin Resistance Gene Detection for First-line H. Pylori Eradication
NCT07439445Helicobacter Pylori Infection
Peking University First Hospital
Not applicable
70
Beijing
2026-04-25
Recruiting
JS212 Combination Therapies in Metastatic Colorectal Cancer
NCT07503756Metastatic Colorectal Cancer
Shanghai Junshi Bioscience Co., Ltd.
Phase 2
80
Shanghai
2026-04-25
Recruiting
High-flow Nasal Cannula Oxygen Therapy Versus Conventional Oxygen Therapy in High-altitude Pulmonary Edema
NCT07536477High-altitude Pulmonary Edema
Third Military Medical University
Not applicable
208
Xigazรช
2026-04-25
Not yet open
Phase II Study of HLX43 Monotherapy or Combined With Immune Checkpoint Inhibitors in Patients With Locally Advanced, Recurrent, or Metastatic Triple-negative Breast Cancer.
NCT07487519Breast Cancer (Triple Negative Breast Cancer (TNBC))
Shanghai Henlius Biotech
Phase 2
180
Harbin
2026-04-25
Recruiting
Spatial Multi-omics and Intelligent Early Warning of Pancreatic Cancer Cachexia
NCT07670286Pancreatic Cancer, Cachexia; Cancer; Sarcopenia
Peking Union Medical College Hospital
Observational
500
Beijing
2026-04-24
Active, closed
A Clinical Study Comparing the Bioequivalence of IBI3027 and DUPIXENTยฎ(Dupilumab) in Healthy Chinese Volunteers
NCT07502534Healthy Volunteers
Innovent Biologics (Suzhou) Co. Ltd.
Phase 1
180
Qingdao
2026-04-24
Recruiting
A Clinical Study on the Treatment of LACC With Cadonilimab Combined With Chemotherapy Followed by CCRT
NCT07400536Locally Advanced Cervical Carcinoma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 3
378
Wuhan
2026-04-24
Recruiting
Tofacitinib for Glucocorticoid-Resistant Moderate-to-Severe Thyroid Eye Disease
NCT07547930Thyroid Eye Disease, TED, Graves Ophthalmopathy, Graves Orbitopathy
The First Affiliated Hospital of Xiamen University
Phase 2
8
Xiamen
2026-04-24
Recruiting
SHR-1701 Combined With Chemotherapy for Gastric or Gastroesophageal Junction Adenocarcinoma With Peritoneal Metastasis
NCT07384234Gastric Adenocarcinoma and Gastroesophageal Junction Adenocarcinoma
Ruijin Hospital
Phase 2
60
Shanghai
2026-04-24
Recruiting
ZYG24002 Lotion to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy in Adult Patients With Mild to Moderate Seborrheic Dermatitis
NCT07404033Seborrheic Dermatitis
Sinomune Pharmaceutical Co., Ltd
Phase 1
48
Suzhou
2026-04-24
Recruiting
A Novel Two-Tooth Clip for ESD and EFTR of GIST
NCT07581977GIST - Gastrointestinal Stromal Tumor
Affiliated Hospital to Academy of Military Medical Sciences
Not applicable
60
Beijing
2026-04-24
Active, closed
Sintilimab Combined With Ipilimumab (N01) Plus AG as First-line Therapy for uBTC.
NCT07654530Biliary Tract Cancers (BTC)
Tianjin Medical University Cancer Institute and Hospital
Phase 2
107
Tianjin
2026-04-24
Recruiting
First-in-Human Expanded Cohort Study of Intrapleural Administration of TolueneSulfonamide in Patients With Malignant Pleural Effusion
NCT07332858Malignant Pleural Effusions (Mpe), Non Small Cell Lung Cancer
Gang Hou
Phase 1/2
105
Beijing
2026-04-24
Not yet open
Improvement Effect of Dexamethasone Enema for Acute Radiation-induced Rectal Injury
NCT07548736Acute Radiation Enteritis
Sixth Affiliated Hospital, Sun Yat-sen University
Phase 2
40
Guangzhou
2026-04-24
Recruiting
A Study to Investigate NPS and Symptoms in Chinese Adult Participants With CRSwNP Initiating Treatment With Tezepelumab
NCT07520162Chronic Rhinosinusitis With Nasal Polyps
AstraZeneca
Phase 3
230
Beijing, Bengbu, Cangzhou, Changchun, Changsha, Chengdu, Chongqing, Foshan
2026-04-24
Recruiting
Re-radiotherapy Combined With Chidamide for the Treatment of Recurrent Head and Neck Squamous Cell Carcinoma After Radiotherapy
NCT07545967Head and Neck Squamous Cell Carcinoma HNSCC
West China Hospital
Phase 1
6
Chengdu
2026-04-23
Recruiting
Effects of IVIG for BPD in Preterm Infant Born at 28 Weeks and Below
NCT07561125Bronchopulmonary Dysplasia
International Peace Maternity and Child Health Hospital
Phase 2
29
Shanghai
2026-04-23
Recruiting
A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)
NCT07419295Bladder Cancer
Merck Sharp & Dohme LLC
Phase 3
590
Beijing, Chongqing, Guangzhou, Zhuhai, Wuhan, Changsha, Nanjing, Nanchang
2026-04-23
Recruiting
A Phase II Clinical Study on the Efficacy and Safety of HRS-1780 in Participants With Primary Aldosteronism
NCT07470983Primary Aldosteronism
Shandong Suncadia Medicine Co., Ltd.
Phase 2
60
Chongqing, Zhengzhou
2026-04-23
Recruiting
Efficacy and Safety of IBI362 in Hypertensive Patients With Overweight/Obesity
NCT07469800Overweight, Obesity, Hypertensive
Innovent Biologics (Suzhou) Co. Ltd.
Phase 3
336
Shanghai
2026-04-23
Not yet open
Prognostic Value of Metabolic Characteristics in High-Risk Populations for Acute Kidney Injury After Cardiac Surgery
NCT07521787Cardiac Surgery Associated - Acute Kidney Injury, Critical Illness
Shanghai Zhongshan Hospital
Observational
540
Shanghai
2026-04-23
Recruiting
CAR 70-BCMA CAR-T Cells for the Treatment of Relapsed or Refractory Plasma Cell Neoplasms
NCT07519187Relapsed or Refractory Plasma Cell Neoplasms
The General Hospital of Western Theater Command
Phase EARLY_PHASE1
20
Chengdu
2026-04-23
Recruiting
Efficacy, Safety, and PopPK Profile of ABP-745 in Patients With Atherosclerosis
NCT07303777Atherosclerosis Cardiovascular Disease, ASCVD, ASCVD Management
Atom Therapeutics Co., Ltd
Phase 2
200
Beijing, Dalian, Guangzhou, Hangzhou, Jinan, Nanjing, Shanghai, Suzhou
2026-04-23
By invitation
Peng's "Fenjin Tuina" for Superior Cluneal Nerve Entrapment Syndrome: A Prospective, Randomized, Single-center Trial
NCT07603154SCNES, Superior Cluneal Nerve Entrapment Syndrome
Guangzhou University of Chinese Medicine
Not applicable
70
Guangzhou
2026-04-23
Recruiting
A Phase I Study of [18F]Flortaucipir PET Imaging in Chinese Subjects: Safety, Pharmacokinetics, Biodistribution, Radiation Dosimetry, and Preliminary Diagnostic Efficacy
NCT07580703AD - Alzheimer's Disease, MCI
Eli Radiopharma
Phase 1
18
Beijing
2026-04-23
By invitation
Wearable-Based Study of Depression and Sleep in Older Adults
NCT07232472Elderly Depression, Sleep Disturbance
China Medical University Hospital
Not applicable
162
2026-04-23
Recruiting
Phase II Study of JS212/JS213 as Monotherapy and in Combination in Patients With Advanced Malignant Solid Tumors
NCT07480733Advanced Malignant Solid Tumors
Shanghai Junshi Bioscience Co., Ltd.
Phase 2
410
Beijing
2026-04-23
Recruiting
SKB103 for Injection in Advanced Solid Tumors
NCT07459998Advanced Solid Tumors
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Phase 1/2
277
Harbin, Shanghai
2026-04-23
Recruiting
A Phase III Study to Evaluate the Efficacy and Safety of Libevitug in Participants With Chronic HDV Infection (D-clear Study)
NCT07499544Chronic Hepatitis D Infection
Huahui Health
Phase 3
160
Changchun, Kashgar, รœrรผmqi
2026-04-22
Recruiting
Efficacy and Safety of Interleukin-6 Receptor Inhibitor Combined With Endovascular Treatment in Patients With Acute Posterior Circulation Large Vessel Occlusion Stroke
NCT07509645Ischemic Stroke
Capital Medical University
Phase 3
348
Suzhou, Anyang, Nanyang, Xinxiang, Zhoukou, Linyi, Zibo, Xianyang
2026-04-22
By invitation
CHT105 for the Treatment of Refractory Lupus Nephritis
NCT07517536Systemic Lupus Erythematosus, Lupus Nephritis
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Not applicable
14
Nanjing
2026-04-22
Recruiting
Digital Technology for Active and Healthy Ageing in Taiwan
NCT07232667Healthy Aging, Digital Health Literacy
China Medical University Hospital
Observational
140
2026-04-22
Active, closed
A Phase I Study of 9MW4113 Injection Versus Dupixentยฎ
NCT07791342Healthy Participants
Mabwell (Shanghai) Bioscience Co., Ltd.
Phase 1
208
Wuhan
2026-04-22
Not yet open
Ongericimab Injection Reducing Recurrence of Ischemic Stroke
NCT07242599Ischemic Cerebral Infarction
Beijing Tiantan Hospital
Phase 3
4,810
Fuyang, Wuhu, Beijing, Chongqing, Ningde, Dingxi, Jiuquan, Lanzhou
2026-04-22
Recruiting
Auricular Acupuncture Therapy Administered by Village Doctors Improves Sleep Quality in Elderly Patients With Comorbid Diabetes Mellitus and Hypertension
NCT07554235Insomnia Disorder, Diabetes, Hypertension
Jiangsu Taizhou People's Hospital
Not applicable
320
Taizhou
2026-04-22
Not yet open
Phase 1 Study of HS-20152 in Healthy Participants
NCT07503015Healthy Volunteers
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Phase 1
32
Qingdao
2026-04-22
Recruiting
A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate Cancer
NCT07365995Metastatic Castration-resistant Prostate Cancer
BioNTech SE
Phase 3
736
Changsha, Chongqing, Hangzhou, Nanchang, Nanjing, Shanghai, Wenzhou, Wuhan
2026-04-22
Recruiting
Effect of Lateral Versus Supine Positions on Postoperative Hypoxemia
NCT07545642Postoperative Hypoxemia
General Hospital of Ningxia Medical University
Not applicable
960
Yinchuan
2026-04-22
Recruiting
Ultra-Hypofractionated vs Moderate Hypofractionated Radiotherapy for Regional Lymph Nodes in High Risk Breast Cancer
NCT07527689Breast Cancer
Ruijin Hospital
Not applicable
1,950
Shanghai
2026-04-22
Recruiting
Study of ZG006 in Combination With PD-1/PD-L1 Immune Checkpoint Inhibitors as First-Line Standard Therapy in Participants With Extensive Stage Small-Cell Lung Cancer
NCT07231445Small Cell Lung Cancer
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Phase 1
100
Shanghai
2026-04-21
Recruiting
A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
NCT07499232Crohn Disease
Janssen Research & Development, LLC
Phase 3
530
Changzhou, Chongqing, Guangzhou, Nanjing, Wuhan
2026-04-21
Recruiting
Bugitinib Combined With Venetoclax and Cytarabine in Relapsed/Refractory Acute Myeloid Leukemia
NCT07563179Acute Myeloid Leukemia, Relapse/Recurrence
Shenzhen University General Hospital
Phase 2
10
Shenzhen
2026-04-21
Active, closed
Implementation of Standardized Early Identification and Diagnosis for Transthyretin Amyloidosis (ATTR) in High-Risk Populations
NCT07338942ATTR-CM
AstraZeneca
Not applicable
4,000
Beijing, Changlexi, Changsha, Chengdu, Chongqing, Dalian, Fuzhou, Guangdong Province
2026-04-21
Recruiting
Accelerated Temporal Interference Stimulation on Bilateral Subthalamic Nucleus for Parkinson's Disease and Secondary Parkinson's Syndrome
NCT07568067Parkinson Disease, Parkinson Disease, Secondary
Ke Dong, MD
Not applicable
60
Guangzhou
2026-04-21
Not yet open
Effects of Different-Frequency Electroacupuncture on Suprahyoid Muscles in Post-Stroke Dysphagia: Efficacy and Neural Networks
NCT07496762Stroke Sequelae, Deglutition Disorders, Acupuncture Therapy, Electroacupuncture
Kaili Chen
Not applicable
90
Hangzhou
2026-04-21
Recruiting
A Study of the Safety and Efficacy of the Intravenous and Intratumoral Injection of OVV-01 in Patients With Advanced Solid Tumours.
NCT07648472Advanced Solid Tumors
Joint Biosciences Ltd.
Phase 1
18
Beijing
2026-04-21
Recruiting
Neoadjuvant Tislelizumab + LM-302 + S-1 or Tislelizumab + SOX for CLDN18.2-Positive Gastric/GEJ Adenocarcinoma
NCT07569068Gastric or Esophagogastric Junction Adenocarcinoma
Ruijin Hospital
Phase 2
88
Shanghai
2026-04-21
Recruiting
A Study of BL-M07D1 Combined With Pertuzumab Versus Docetaxel Plus Trastuzumab and Pertuzumab in Patients With First-line HER2-positive Recurrent or Metastatic Breast Cancer
NCT07518173HER2-positive Breast Cancer
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 3
596
Guangzhou, Chengdu
2026-04-21
Recruiting
JS212 Plus JS111 in EGFR-Mutant Advanced NSCLC: A Phase II Study
NCT07518160Locally Advanced, Metastatic, or Recurrent Non-small Cell Lung Cancer (NSCLC) Harboring Epidermal Growth Factor Receptor (EGFR) Mutations
Shanghai Junshi Bioscience Co., Ltd.
Phase 2
35
Shanghai
2026-04-21
Recruiting
Ultra-early Identification of Futile Recanalization After Reperfusion Therapy in Acute Ischemic Stroke Based on Cerebral Autoregulation
NCT07556068Acute Ischemic Stroke, Cerebral Autoregulation
Beijing Shijitan Hospital, Capital Medical University
Observational
129
Beijing, Harbin, Dalian, Weifang
2026-04-20
Not yet open
A Comparative Analysis of Mid- to Long-Term Outcomes: Paclitaxel-Coated Balloon With Debulking Versus Paclitaxel-Coated Balloon Alone in the Treatment of Chronic Femoropopliteal Artery Occlusions
NCT07406308Femoropopliteal Artery Occlusion
Peking Union Medical College Hospital
Phase EARLY_PHASE1
408
Beijing
2026-04-20
Recruiting
Tissue Engineered Cartilage to Repairing Articular Cartilage Defects
NCT07094100Cartilage Injury, OA Knee
The First Affiliated Hospital of Xinxiang Medical College
Not applicable
30
Xinxiang
2026-04-20
Recruiting
CDK4/6 Inhibitors Combined With Endocrine Therapy for Neoadjuvant Treatment
NCT07366112Hormone Receptor-Positive Breast Cancer, High-risk Breast Cancer, Early-Stage Breast Cancer, HER2-negative Breast Cancer
Peking University People's Hospital
Phase 2
158
Beijing
2026-04-20
Not yet open
Efficacy and Safety of SKB264 Plus Anlotinib in EGFR-TKI-Resistant Advanced NSCLC With Liver Metastasis
NCT07545213Non-small Cell Lung Cancer, EGFR Mutant Advanced Non-small Cell Lung Cancer
The Fourth Affiliated Hospital of Zhejiang University School of Medicine
Phase 2
27
Yiwu
2026-04-20
Recruiting
QLC5508 vs. Chemotherapy in Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma
NCT07463573Esophageal Squamous Cell Carcinoma (ESCC)
Qilu Pharmaceutical Co., Ltd.
Phase 3
466
Beijing
2026-04-20
Not yet open
Esomeprazole Plus Sucralfate for Post-ESD Ulcer Healing
NCT07312370Early Gastric Cancer, Gastric Dysplasia, Gastric Neoplasms, Peptic Ulcer With Haemorrhage
LanZhou University
Phase 4
120
Lanzhou
2026-04-20
Rows per page Showing 2601–2700 of 19052
Previous 25 26 27 28 29 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site. Derived from ClinicalTrials.gov. Retrieved 23 September 2026. https://priyalifescience.com/clinical-trials-china?page=27

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →
→

Browse trials by condition

Breast Cancer (416) Advanced Solid Tumors (183) Gastric Cancer (183) Colorectal Cancer (179) Hepatocellular Carcinoma (161) Advanced Solid Tumor (159) Solid Tumor (145) Non-Small Cell Lung Cancer (144) Acute Ischemic Stroke (138) Lung Cancer (134) Pancreatic Cancer (132) Non-small Cell Lung Cancer (131) Multiple Myeloma (126) Coronary Artery Disease (111) Prostate Cancer (111)
→

Browse trials by site location

Beijing (5484) Shanghai (3827) Guangzhou (3318) Hangzhou (1812) Wuhan (1343) Chengdu (1291) Nanjing (1193) Changsha (1154) Chongqing (1056) Fuzhou (1018) Tianjin (940) Zhengzhou (921) Hefei (875) Jinan (785) Changchun (641)
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.